Regardless of one�� views on the Fed and Ben Bernanke, investors will have to come to terms with the inevitability of higher rates going forward. Yet, this shouldn�� spook the market, as it�� an indication the global economy is finally pulling itself from the crater created by the implosion of Lehman Brothers and the ensuing financial crisis. Indeed, a host of opportunities are out there to position portfolios to face the coming market phase, from looking at equities and major banks in the U.S., to REITs and increasing exposure to core Europe to take advantage of deals overseas. Investors, though, should be careful of potential shocks including political bickering in Washington and across the Eurozone, and should avoid bonds and defensive stocks.
Bernanke is expected leave the Fed in early 2014, but his policies are set to endure, suggesting the Fed is taking its foot off the gas - Image credit: Getty Images via @daylife
5 Best Low Price Stocks To Buy Right Now: Helix Energy Solutions Group Inc (HLX)
Helix Energy Solutions Group, Inc.( Helix), incorporated on November 17,1983, is an international offshore energy company that provides specialty services to the offshore energy industry, with a focus on its growing well intervention and robotics operations. The Company had had two business segments: Contracting Services and Production Facilities. Its Contracting Services seek to provide services and methodologies which it believes are critical to developing offshore reservoirs and maximizing production economi regions. Its Production Facilities segment consists of its majority ownership of a dynamically positioned floating production vessel ( Helix Producer I or HP I). In June 2013, Helix Energy Solutions Group Inc closed the previously announced sale of its pipelay vessel, the Caesar, to Trevaskis Ltd.
In January 2012, it sold its oil and gas properties within the Main Pass area of the Gulf of Mexico. On September 26, 2012, the Company sold its pipelay vessel, Intrepid, to Stabbert Maritime Holdings, LLC. On February 6, 2013, it sold Energy Resource Technology GOM, Inc. (ERT), a former wholly-owned United States subsidiary that conducted its oil and gas operations in the Gulf of Mexico.
Contracting Services Operations
The Company provides services and methodologies which it believes are critical to developing offshore reservoirs and maximizing production economics. Its life of field services are segregated into four disciplines: well intervention, robotics, subsea construction and production facilities. It provides a full range of contracting services primarily in the Gulf of Mexico, North Sea, Asia Pacific and West Africa regions primarily in deepwater.
The Company's services include production, which includes inspection, repair and maintenance of production structures, trees, jumpers, risers, pipelines and subsea equipment, well intervention, life of field support and intervention engineering; reclamation and remediation services include pluggin! g and abandonment services, pipeline abandonment services and site inspections; installation of subsea pipelines, flowlines, control umbilicals, manifold assemblies and risers, pipelay and burial, installation and tie-in of riser and manifold assembly, commissioning, testing and inspection, and cable and umbilical lay and connection. It provides oil and natural gas processing services to oil and natural gas companies, primarily those operating in the deepwater of the Gulf of Mexico using its HP I vessel. The HP I is being utilized to process production from the Phoenix.
The Company engineers, manages and conducts well construction, intervention and asset retirement operations in water depths ranging from 200 to 10,000 feet. Three of its vessels serve as work platforms for well intervention services at costs that are typically significantly less than offshore drilling rigs. In the Gulf of Mexico, its multi-service semi-submersible vessel, the Q4000, has set a series of well intervention firsts in increasingly deeper water without the use of a traditional drilling rig. In August 2012, it acquired the Discoverer 534 drillship from a subsidiary of Transocean Ltd.
The Company operates remotely operated vehicles ( ROVs), trenchers and ROVDrills designed for offshore construction and well intervention services. As global marine construction support moves to deeper water. Its chartered vessels add value by supporting deployment of its ROVs. It provides its customers with vessel availability and schedule flexibility to meet the technological challenges of their subsea activities worldwide. Its robotics assets include 49 ROVs, four trencher systems and two ROVDrills. It operate in the Gulf of Mexico, North Sea, Asia Pacific and West Africa regions. It charters four vessels to support its robotics operations and it has engaged additional vessels on short-term (spot) charters as needed. In 2012, its robotics operations had 377 vessel utilization days and 16% of global revenues derived from! alternat! ive energy contracts. Subsea construction services include the use of umbilical lay and pipelay vessels and ROVs to develop fields in the deepwater.
The Company owns interests in two production facilities in hub locations where there is potential for subsea tieback activity. It has invested in two over-sized facilities that allow the operators of these fields to tie back without burdening the operator of the hub reservoir. It owns a 50% interest in Deepwater Gateway, which owns the Marco Polo TLP located in 4,300 feet of water in the Gulf of Mexico. It also owns a 20% interest in Independence Hub which owns the Independence Hub platform, a 105-foot deep draft, semi-submersible platform located in a water depth of 8,000 feet that serves as a regional hub for up to one billion cubic feet (Bcf) of natural gas production per day from multiple ultra-deepwater fields in the eastern Gulf of Mexico.
The Company competes with Oceaneering International, Inc., Saipem S.p.A., Fugro N.V., DOF ASA, Aker Solutions ASA, Subsea 7 S.A., Technip, McDermott International, Inc., Island Offshore and Edison Chouest Offshore Companies.
Advisors' Opinion:- [By David Smith]
Helix Energy Solutions Group (NYSE: HLX )
At $2.70 billion in market capitalization, Helix is equidistant between Flotek and Superior from a size perspective. The company operates through two segments: contracting services and production facilities. - [By GuruFocus]
Helix Energy Solutions Group Inc (HLX): PRESIDENT & CEO Owen E Kratz Bought 50,000 Shares PRESIDENT & CEO of Helix Energy Solutions Group Inc (HLX) Owen E Kratz bought 50,000 shares on 10/24/2013 at an average price of $24.03. Helix Energy Solutions Group Inc has a market cap of $2.54 billion; its shares were traded at around $24.03 with and P/S ratio of 2.96.
10 Best Defensive Stocks To Watch For 2014: Adelaide Resources Ltd (ADN)
Adelaide Resources Limited is an Australia-based company engaged in the exploration for gold, copper, uranium, and other economic mineral deposits. As on June 30, 2012, the Company has interests in 22 exploration licenses, covering over 7,800 square kilometers within South Australia, the Northern Territory and Queensland. The Company holds 100% of the majority of the Moonta Project on Yorke Peninsula in South Australia and a program of aircore and diamond drilling was completed in early 2012 to test a number of targets. The Company�� projects include Rover, Eyre Peninsula, Eyre Peninsula Basement, Yalanda Hill JV, Corrobinnie Palaeochannel Project, Cleve, Anabama, Moonta and Glenroy. The Company subsidiaries include Adelaide Exploration Pty Ltd and Peninsula Resources Limited (formerly Eyre Energy Pty Ltd) Advisors' Opinion:- [By Tom Stoukas]
Aberdeen Asset Management Plc (ADN), Scotland�� largest money manager, lost 7.9 percent to 368.5 pence as Goldman Sachs Group Inc. downgraded the stock to neutral from buy.
- [By Sofia Horta e Costa]
Aberdeen Asset Management Plc (ADN) dropped 1.7 percent to 415.7 pence, the lowest price in six weeks. Bank of America Corp.�� Merrill Lynch unit cut its rating on Scotland�� largest money manager to underperform, similar to a sell recommendation, from neutral, saying the stock�� price is unjustified given slowing earnings growth.
10 Best Defensive Stocks To Watch For 2014: Quest Diagnostics Inc (DGX)
Quest Diagnostics Incorporated (Quest Diagnostics), incorporated in 1990, is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. Its diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. On April 4, 2011, the Company acquired Athena Diagnostics (Athena). On May 17, 2011, the Company acquired Celera Corporation (Celera). In January 2012, the Company acquired S.E.D. Medical Laboratories. In December 2012, the Company sold all of the assets of OralDNA Labs salivary-diagnostics business to Access Genetics. Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. In January 2012, it acquired S.E.D. Medical Laboratories. In December 2012, it sold all of the ! assets of OralDNA Labs salivary-diagnostics business to Access Genetics. In January 2013, the Company acquired the Worcester -based clinical outreach laboratory business of UMass Memorial Medical Center.
Clinical Testing
The Company is a commercial clinical testing company. Physicians use clinical tests to assist in the detection, diagnosis, evaluation, monitoring and treatment of diseases and other medical conditions. Clinical testing is generally categorized as clinical laboratory testing and anatomic pathology services. The Company offers customers the access to the test menu of clinical laboratory and anatomic pathology tests in the United States. Clinical laboratory testing generally is performed on whole blood, serum, plasma and other body fluids, such as urine, and specimens such as microbiology samples.
The Company is a provider of routine clinical testing, including testing for drugs of abuse. The Company performs routine testing through its network of laboratories and rapid response laboratories. The Company also performs routine testing at hospital laboratories that the Company manages. The Company operates laboratories round the clock. The majority of test results are delivered electronically. Routine tests measure various bodily health parameters, such as the functions of the kidney, heart, liver, thyroid and other organs. Commonly ordered tests include blood chemistries, including cholesterol levels; complete blood cell counts; urinalysis; pregnancy and other prenatal tests, and routine microbiology testing.
The Company is a provider of anatomic pathology services in the United States, through its AmeriPath, Dermpath Diagnostics and Quest Diagnostics brands. Anatomic pathology involves the diagnosis of cancer and other diseases and medical conditions through examination of tissue and cell samples taken from patients. The Company provides inpatient anatomic pathology and medical director services at hospitals throughout the country, and through ! its labor! atories. The Company provides a range of services to all anatomic pathology subspecialties. The Company provides integrated, reports that include both anatomic pathology and clinical pathology tests, enabling its pathologists to offer patients and physicians a complete analysis. The Company introduced the Leumeta family of tests for leukemia and lymphoma.
The Company is a provider in the United States of gene-based and esoteric testing. Esoteric tests include procedures in the areas of molecular diagnostics, protein chemistry, cellular immunology and advanced microbiology. Commonly ordered esoteric tests include viral and bacterial detection tests, drug therapy monitoring tests, genetic tests, autoimmune panels and complex cancer evaluations. During the year ended December 31, 2011, it acquired Athena Diagnostics, a provider of neurology testing. Its esoteric laboratories provide reference testing services to physicians, academic medical centers, hospitals and other commercial laboratories. The Company also offers gene-based tests for the predisposition, diagnosis, treatment and monitoring of cancers. The Company develops tests at its laboratories, such as Quest Diagnostics Nichols Institute. It also develops techniques and services in anatomic pathology.
In 2011, the Company introduced its melanoma treatment selection mutation panel, which is designed to assist in the personalized selection of patient therapies. The Company introduced its thyroid cancer mutation panel, which assists in the diagnosis of thyroid cancer and aids physicians and surgeons as they plan surgery and other therapies to treat and attempt to cure thyroid cancer. During 2011, it enhanced its SureSwab Vaginosis/Vaginitis Plus test. The Company introduced Accutype IL28b, a test designed to aid in the prediction of patient response to peginterferon alpha-based therapy for treating hepatitis C virus infection. In 2011, it introduced testing for very long chain fatty acids, to assist in diagnosis and monitori! ng of inh! erited disorders of fatty acid metabolism. It also introduced high resolution chromosomal analysis testing with oligonucleotide microarrays to enhance its testing services in the pre-natal and post-natal genetics areas. During 2011, the Company released a test for therapeutic drug monitoring of dabigatran, an oral anti-coagulant. The Company also released genetic testing for SLC01B1, which helps identify patients at risk for myopathy from Simvastatin therapy for cholesterol reduction. Through Athena Diagnostics, it launched several molecular genetic tests for stroke, neuromuscular diseases and mitochondrial disorders.
Healthcare Information Technology
The Company provides interoperable technologies that help healthcare organizations and physicians enter, share and access clinical information without costly information technology (IT) implementation or workflow disruption, including through its Care360 suite of products and its ChartMaxx electronic document management system for hospitals. These solutions offer access to a national healthcare provider network, including approximately 200,000 networked physicians and clinicians using Quest Diagnostics��Care360 connectivity products. The Care360 products, including its Care360 Labs and Meds, enable physicians electronically to order diagnostic tests and review test results from Quest Diagnostics and electronically to prescribe medication. As of December 31, 2011, prescriptions were written through Care360 ePrescribing at an annualized rate of 32 million medications. Using its Care360 connectivity products, physicians can securely provide diagnostic and other data to a patient�� account. It offers Gazelle, a secure mobile health platform that allows users to receive their Quest Diagnostics laboratory results, manage their personal health information, find a Quest Diagnostics location and schedule appointments directly from their smartphone.
Clinical Trials Testing
The Company is a provider of central l! aboratory! testing performed in connection with clinical research trials on new drugs, vaccines and certain medical devices. It has clinical trials testing centers in the United States and the United Kingdom, and it provides clinical trials testing in Argentina, Australia, Brazil, the People�� Republic of China and Singapore through affiliated laboratories. The Company has biomarker capabilities. In 2011, it acquired Celera, enhancing its ability to provide biomarker discovery and develop IVD test kits.
Life Insurer Services
The Company is a provider of risk assessment services to the life insurance industry in North America. It also provides risk assessment services for insurance companies doing business in many countries outside the United States. Its risk assessment services comprise underwriting support services to the life insurance industry, including laboratory testing, electronic data collection, specimen collection and paramedical examinations, medical record retrieval, case management, motor vehicle reports, telephone inspections, prescription histories and credit checks. The laboratory tests that it performs and data it gathers are designed to assist insurance companies to objectively evaluate the mortality risks of policy applicants. The majority of the testing is performed on specimens of life insurance applicants, but also includes specimens of applicants for other types of insurance. Most of its specimen collections and paramedical examinations are performed by its network of approximately 5,000 contracted paramedical examiners at the applicant�� home or workplace. The Company also offers paramedical examinations through approximately 500 of its patient service centers, and operate approximately 80 locations other than patient service centers in the United States and Canada where the Company provides paramedical examinations, bringing to approximately 580 the total number of sites where it can provide these examinations. The Company also contracts with third parties at over! an addit! ional 200 locations globally to coordinate providing these exams.
Employer Services
The Company is a provider of testing to employers for the detection of employee use of drugs of abuse. Its Quest Diagnostics Drug Testing Index, which is an annual report of its aggregate drug testing results, is used by employers, the federal government and the media to help identify and quantify drug abuse among the nation�� workforce. It provides a range of solutions for drugs of abuse, including urine, hair, blood and oral fluid tests. In 2011, it introduced Oral-Eze, its own oral fluid collection system that simplifies the collection of oral samples for routine drug testing. The Oral-Eze Oral Fluid Collector provides all the advantages of previous collection systems, with the added benefit of its indicator window technology. The Company provides wellness testing and analytic services to employers.
Diagnostic Products
Diagnostic Products include point-of-care, or near-patient and testing. The Company develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including products for point-of-care, or near-patient, testing for the professional market. The Company has several companies, including Focus Diagnostics, HemoCue and Celera. Focus Diagnostics is a provider of infectious disease testing. Focus Diagnostics develops, manufactures and markets diagnostic products, such as HerpeSelect ELISA tests that detect patient antibodies to specific types of herpes simplex virus, which can be performed on a variety of instrument platforms. Focus Diagnostics sells its diagnostic products to academic medical centers, hospitals and commercial laboratories globally. Focus Diagnostics has an agreement with 3M Corporation for global human diagnostic rights to a compact integrated bench-top instrument for use with real time polymerase chain reaction (PCR) assays. These tests are sold under the Simplexa brand name. In 2011, Focus Diagnostic! s receive! d the CE mark to offer Simplexa tests in Europe, including tests for Cytomegalovirus, Epstein Barr virus, BK virus and clostridium difficile. Focus Diagnostics offers molecular transplant-testing menus in Europe.
HemoCue manufactures and distributes point-of-care testing products globally. HemoCue is a global provider in point-of-care testing for hemoglobin, with a growing market share for glucose, microalbumin and white blood cell testing. HemoCue offers its White Blood Cell Differential System in Europe. Celera offers complexity molecular diagnostic products in segments, such as HIV-1 drug resistance testing, reproductive genetics, transplantation and cardiovascular genetics. It also manufactures and offers the InSure fecal immunochemical test (FIT) for screening for colorectal cancer.
The Company competes with Laboratory Corporation of America Holdings, Inc.
Advisors' Opinion:- [By Ben Levisohn]
As a result, LabCorp has dropped 11% to $87.79 and has helped drag down competitors like Quest Diagnostics (DGX), and BioReference Laboratories (BRLI).
- [By Ben Fox Rubin]
Medical-testing services provider Quest Diagnostics Inc.(DGX) raised the low end of its 2013 profit estimate, a rosier view that comes two days after rival Laboratory Corp. of America Holdings issued a disappointing 2014 outlook.
- [By Sean Williams]
Thinking really long-term
Sometimes we need to put on our Warren Buffett goggles and think like Buffett if we hope to find the market's best buy-and-hold opportunities. This week I feel could represent the perfect opportunity to nab shares of medical diagnostics company Quest Diagnostics (NYSE: DGX ) , which are still relatively close to a 52-week low.
10 Best Defensive Stocks To Watch For 2014: Orange SA (ORAN)
Orange SA, formerly France Telecom S.A., incorporated on December 31, 1996, is an European mobile operator, an asymmetric digital subscriber line (ADSL) Internet access provider in Europe, and telecommunications services provider for multinational businesses under the Orange Business Services brand. As of December 31, 2010, France Telecom provided services to 209 million customers, of which 150 million were mobile phone customers and 13.7 million were broadband Internet customers, and as of June 30, 2011, provided services to 217.3 million customers. It offers its individual customers, businesses and other telecommunications operators a line of services covering fixed and mobile communications, data transmission, the Internet and multimedia, and other services. The Company�� segments include France, Poland, Spain, Rest of the World, Business Communication Services, International Carriers and Shared Services.
France
The range of services in the Home segment in France is made up of fixed-line telephony services; other consumer services; online, Internet access, and multimedia services; advertising-management and Internet portal business; content-related business, and carrier services. France Telecom�� traditional fixed-line telephony services provide access to the network, local and long-distance telephone communication services throughout France, and international calls. In addition, France Telecom offers its fixed-line telephony subscribers a broad range of value-added services. The France Telecom Group has a number of portals, including Orange.fr, which is either Web- or mobile-accessible. In December 2010, its audience reached 22.5 million, and Voila.fr and Cityvox (entertainment and leisure listing site in France) in its different formats, such as Cityvox.fr, Cinefil.com, Spectacles.fr, Concert.fr and WebCity.fr. The primary revenue source is online advertising sold by the Orange Advertising Network. This advertising management department sells advertising space for ab! out 20 third-party sites, both Web and mobile.
Orange�� offers are built around three product lines: postpaid, prepaid and convergent offers. Orange offers two categories of prepaid offer, to which calls are charged by the second from the first second: The Mobicarte, includes a range of recharges from 5 to 100 euros and Orange Initial, which enables the customer to be billed monthly depending on his or her actual consumption. Orange also has a number of offers that pair mobile use and mobile Internet access with all-in-one offers, including both the hardware and an Internet access plan. The USB 3G+ plans enable connection to the Internet via the mobile broadband network or the Orange public wireless fidelity (WiFi) network from a laptop computer, multimedia mobile phone or a tablet personal computer.
The Company competes with SFR-Neuf Cegetel, Free, Bouygues Telecom, Numericable, Google and Voila.
Poland
Orange (the brand under which the TP Group subsidiary, PTK Centertel trades) had a total of 14.3 million during the year ended December 31, 2010. In April 2010, PTK Centertel introduced segmented postpaid offers for residential customers. Depending on the usage profile, customers can choose from three types of tariff plans: Dolphin tariffs for frequent users of voice services, Pelican for customers focused on text and community Web-services, and Panther for users of mobile data services (Internet, email). The mobile broadband Internet customer base (Edge and 3G data services) reached 547,000 customers during 2010. In 2010, Orange introduced a SIM-only mobile Internet offer and a portfolio of terminals dedicated to the Orange Free offer.
The Company competes with Netia, Multimedia Polska, Aster and Hyperion.
Spain
Orange Espana, operating under Orange, Ya.com and OBS (Enterprise) brands offers fixed and mobile telecommunication services to more than 13 million customers in the residential, professional, business and who! lesale se! gments. Orange Espana�� physical distribution network consists in 2,922 points of presence, including Orange own shops, franchises, specialized shops under the Orange brand, non exclusive specialized shops, and a network of retailers. Orange Espana also distributes its services through distance selling channels, and its own online portal. Orange Espana fixed access infrastructure, based on its own optic fiber network and ADSL roll-out, enables delivery of advanced telecommunication services, including broadband Internet access, voice over Internet protocol (VoIP), internet protocol television (IPTV), television (TV) streaming, video on demand (VOD) and advanced business services.
The Company competes with Telefonica, ONO, Vodafone and Jazztel.
Rest of the world
The France Telecom Group is present in Luxembourg via Orange S.A. (formerly VOXmobile), a wholly owned subsidiary of Mobistar. The Luxembourg subsidiary, VOXmobile, was renamed Orange S.A. in October 2009. During the year ended December 31, 2010, Orange S.A. had 88,900 active mobile telephony customers.
The Company competes with Proximus, Mobistar, Base, ex-Mobifon, Telefonica O2, Deutsche Telekom, Swisscom, Sunrise, Moldtelecom, Starnet, ECMS, Vodafone Egypt and Etisalat U.A.E.
Enterprise Communications Services
The Orange Business Services brand covers both the Enterprise Communication Services (ECS) unit, which supplies communications services to multinational companies and corporate accounts and small and medium enterprises (SMEs) in France and Orange subsidiaries Business-to-Business (B2B) activities.
Orange Business Services covers the Company�� business customers in more than 160 countries and regions where it provides local technical and commercial assistance. This business segment includes a number of subsidiaries, including Etrali (trading solutions), Almerys (health), Orange Consulting (project management, telecom consulting), Multimedia Business Se! rvices (m! ultimedia contact centers), Neocles (virtualization solutions), IT&Labs (design and development of embedded Machine-to-Machine applications, vehicle fleet management), Obiane and Telecom System (secure network integration), Alsy (integration services), EGT (equipment and services for video conferences), and GlobeCast (multimedia broadcast systems).
The Company competes with IBM, HP, Microsoft and Cisco.
The Company competes with COLT Telecom, Numericable-Completel, BT Global Services, AT&T Business Services, Verizon Business, T-Systems, Reliance Globalcom, Tata Communications, Belgacom Group, NextiraOne, Spie Communication, NTT Group, IBM Global Services, HP Enterprise Services, Atos Origin, Salesforce and Amazon.
International Carriers and Shared Services
Orange�� International Carriers activity is based on long-distance network infrastructure and offers a range of solutions on the international market. The Company is involved in the design, construction and operation of submarine cables. The Company�� wholesale activity includes a worldwide network with over 120 presence points and 130,000 kilometers of fiber optic cable; a worldwide network of Internet protocol (IP) routes with end users in over 220 countries and connections to over 250 Internet service providers and a hit rate of over 85% for all European net surfers. France Telecom�� network has over 330 direct routes and interconnections with over 359 operators, and coverage in over 900 destinations with around-the-clock technical support. Its range of solutions includes interconnection, interoperability and signaling solutions for messaging, voice and video telephony services and the Orange Roaming Hub (Global eXchange) solution for moving from a bilateral model to a multilateral roaming system.
France Telecom has developed activities related to its core business line, such as content broadcasting, audience and advertising, and also healthcare activities. Orange offers free a! nd paying! content on its own channels, paid program packages, Video On Demand, music and game offers. Orange distributes content provided by third parties (television, games, music) on fixed-line and mobile networks both inside and outside France. Orange also produces its own channels: Orange Sport and Orange Cinema�� five different channels. Studio 37, is a subsidiary for investing in cinematographic rights, through both co-production and the acquisition of catalogue rights. During the year ended December 32, 2010, Studio 37 supported the launch of 15 films, including the Gainsbourg and Fatal. The Viaccess group, a France Telecom subsidiary, offers access solutions to television content. Orange is present in the games market through the games it sells on the orange.fr portal (Casual Games dedicated to family type games, such as breakout clones or riddles). Orange Healthcare, is the Company�� healthcare division, focused on developing service packages for the whole sector within a partnership approach.
The Company competes with Telefonica, Deutsche Telekom, Telia Sonera and AT&T.
Advisors' Opinion:- [By Sean Williams]
Also in the news ...
Let's not sugarcoat this one iota: It was a really busy week for earnings news, with network equipment maker QLogic (NASDAQ: QLGC ) , printing and IT specialist Xerox (NYSE: XRX ) , and telecommunication services provider Orange (NYSE: ORAN ) all reporting results. - [By Barel Karsan]
About a year ago, Orange (ORAN) was brought up on this site as a potential value investment. (Back then, we knew it as France Telecom (FTE).) Sentiment was in the toilet. A weak European economy combined with new regulations and an upstart competitor scared investors away, resulting in price to free cash flow ratios in the single digits. But these are exactly the conditions under which investors should be buying. When temporary issues (and there were a trifecta here!) affect a historically profitable business in an industry with barriers to entry, it can create a buying opportunity if investors are running scared. That appears to have been what happened here. The regulatory issues eased up as did the competitive environment, and shares of Orange have risen 60% to what I would consider a more appropriate valuation. Some of the comments I received when I wrote the article last year include: "FTE will end, but I think it has more than enough strength to limp on for another decade at least, dragging on yield hungry investors that don't know any better." "Lets not look at the horrible French economy" "worsening unemployment" "government that loves to socialize, ruin their private businesses" "It's been in decline year after year after year." Such macro-economic, backward-looking forecasts have no place in value investing! Go against the crowd.Disclosure: No position
- [By Lisa Levin]
Orange (NYSE: ORAN) shares reached a new 52-week high of $14.95. Orange's PEG ratio is 0.38.
Rice Energy (NYSE: RICE) shares gained 2.21% to touch a new 52-week high of $28.65. Rice Energy is expected to post earnings of $0.10 in the June quarter.
- [By Sean Williams]
Finally, because three isn't a crowd when it comes to receiving dividends, we received our $0.2637 per share distribution from France Telecom (NYSE: ORAN ) . France Telecom pays out two semi-annual dividends each year that can vary wildly in size. Like Exelon, France Telecom reduced its dividend by more than 40% recently, but is still pledging to deliver what would equate to at least 0.80 euros ($1.07) this year. �That would equate to a yield of 10.8% based on yesterday's closing price, and the prospect of nearly an $0.80 dividend being announced later this summer. Don't be surprised if you see income seekers jumping into France Telecom in the coming months.
10 Best Defensive Stocks To Watch For 2014: FedEx Corporation(FDX)
FedEx Corporation provides transportation, e-commerce, and business services in the United States and internationally. It operates in four segments: FedEx Express, FedEx Ground, FedEx Freight, and FedEx Services. The FedEx Express segment offers various shipping services for the delivery of packages and freight. This segment also provides international trade services specializing in customs brokerage, and ocean and air freight forwarding services; customs clearance services, as well as global trade data, an information tool that allows customers to track and manage imports; and international trade advisory services, including assistance with the customs-trade partnership against terrorism program, as well as publishes customs duty and tax information in various customs areas. In addition, it offers supply chain solutions, including critical inventory logistics, transportation management, fulfillment, and fleet services. The FedEx Ground segment provides business and reside ntial ground package delivery services. It primarily serves customers in the small-package market in North America. The FedEx Freight segment offers less-than-truckload freight services, as well as freight-shipping services. As of May 31, 2010, this segment operated approximately 60,000 vehicles and trailers from a network of 492 service centers. The FedEx Services segment provides sales, marketing, information technology support, and customer service support services; and access to copying and digital printing through retail and Web-based platforms, signs and graphics, professional finishing, computer rentals, and a range of ground shipping and time-definite express shipping services. The company was founded in 1971 and is headquartered in Memphis, Tennessee.
Advisors' Opinion:- [By Riddhi Kharkia]
While, e-commerce has sabotaged the high revenue times of the brick-and-mortar retailers and left them with squeezed margins, it has done well for another industry. I am talking about the supply chain and cargo industry, which has gained from this surge in e-commerce as it has expanded reach and brought affordability to many households. One of the companies in this industry that has benefitted by this trend and has been on the high horse since the beginning of the year, is FedEx (FDX). This betterment in operations and increasing confidence of investors is evidenced by the 30% surge in stock price over the last 12 months. The company, founded in 1971 and based in Memphis, Tennessee, had a great earnings report recently and, going into the Christmas season, would appear to be a nice play for investors.
- [By Jesse Solomon]
Investors will pay close attention to earnings from UPS (UPS) on Tuesday. The shipping giant and FedEx (FDX) rival blamed its poor first quarter performance on that nasty winter weather, but market strategists are expecting the company's earnings picked up steam last quarter along with the economy.
10 Best Defensive Stocks To Watch For 2014: PowerShares WilderHill Clean Energy Portfolio (PBW)
PowerShares WilderHill Clean Energy Portfolio (the Fund) is based on the WilderHill Clean Energy Index and seeks investment results that correspond generally to the price and yield (before the Fund�� fees and expenses) of that equity index. The sectors covered by the Fund include Energy-Alternate Sources, Semiconductors, Electrical Components and Equipment, Chemicals, Electric, Electronics, Computers, Auto Parts and Equipment, Biotechnology and Agriculture. PowerShares Capital Management LLC is the Fund's investment adviser.
PowerShares WilderHill Clean Energy Portfolio�� top 10 holdings include SunPower Corp., Class A, Echelon Corp., Cypress Semiconductor Corp., Cree, Inc., First Solar, Inc., OM Group, Inc., Universal Display Corp., KYOCERA Corp. ADR (Japan), Suntech Power Holdings Co., Ltd. ADR (Cayman Islands) and Applied Materials, Inc.
Advisors' Opinion:- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some clean-energy-related stocks to your portfolio, the PowerShares WilderHill Clean Energy Portfolio ETF (NYSEMKT: PBW ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The PowerShares ETF's expense ratio -- its annual fee -- is 0.70%. The fund is fairly small, too, so if you're thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in. - [By Wall Street Sector Selector]
Another ETF which invests in the solar sector is the PowerShares WilderHill Clean Energy ETF (PBW). Although its holdings are not limited to the solar sector, its most significant holding is SunPower Corporation at 4.96% of the weight. Its number three holding is MEMC Electronic Materials at 3.42% of the weight. PBW's average trading volume is robust at over 400,000 shares per day. Its market cap is $135 million.
- [By Aaron Levitt]
A lack of profits and the reliance on government subsidies have made most stocks in the renewable energy category pretty poor performers over the years. Just check out the performance of the broad PowerShares WilderHill Clean Energy ETF (PBW). It has lost about 7.5% annually since its inception in 2005.
10 Best Defensive Stocks To Watch For 2014: Renewable Energy Group Inc (REGI)
Renewable Energy Group, Inc., incorporated in August 2006, is a producer of biodiesel in the United States. The Company is engaged in each aspect of biodiesel production, from acquiring feedstock, managing construction and operating biodiesel production facilities to marketing, selling and distributing biodiesel and its co-products. During the year ended December 31, 2011, the Company sold approximately 150 million gallons of biodiesel. As of December 31, 2011, the Company operated a network of six biodiesel plants, with an aggregate production capacity of 212 million gallons per year. On July 12, 2011, the Company acquired SoyMor Biodiesel, LLC (SoyMor), which has 30 million gallons per year biodiesel production facility in Albert Lea, Minnesota. In January 2012, it exercised its option to purchase the 60 million gallons per year facility in Seneca, Illinois, which it operated under a lease. In August 2013, the Company acquired biodiesel plant in Mason City, Iowa. In January 2014, Renewable Energy Group Inc acquired renewable chemical technology developer LS9, Inc.
The Company produces its biodiesel from a range of feedstocks, including inedible animal fat, used cooking oil and inedible corn oil. It also produces a smaller portion of its biodiesel from virgin vegetable oils. It owns biodiesel production facilities with capacities consisting of 12 million gallons per year facility in Ralston, Iowa; 35 million gallons per year facility near Houston, Texas, or the Houston facility; 45 million gallons per year facility in Danville, Illinois, and 30 million gallons per year facility in Newton, Iowa.
The Company competes with Archer Daniels Midland Company, Cargill, Incorporated, Louis Dreyfus Commodities Group, Ag Processing Inc., Mansfield, Astra, Gavilon, Tenaska, ED&F Man, Dynamic Fuels, LLC, Syntroleum Corporation, Tyson Foods, Inc., Diamond Green Diesel, LLC and Darling International.
Advisors' Opinion:- [By Roberto Pedone]
Renewable Energy Group (REGI) is a producer of biodiesel in U.S. This stock closed up 11.5% at $15.59 in Wednesday's trading session.
Wednesday's Volume: 1.59 million
Three-Month Average Volume: 634,616
Volume % Change: 235%From a technical perspective, REGI exploded higher here right off its 50-day moving average of $13.83 with heavy upside volume. This move pushed shares of REGI into breakout and all-time high territory, since the stock flirted with some near-term overhead resistance levels at $14.75 to its former all-time high at $15.71. At last check, REGI closed near the highs of the day at $15.75 and volume was well above its three-month average action of 634,616 shares.
Traders should now look for long-biased trades in REGI as long as it's trending above its 50-day at $13.83 and then once it sustains a move or close above its new all-time high of $15.75 with volume that's near or above 634,616 shares. If we get that move soon, then REGI will set up to enter new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $20 to $22.
- [By Maxx Chatsko]
Renewable Energy Group (NASDAQ: REGI ) The nation's largest biodiesel producer has been one of my favorite companies to watch in the last year. It appears that the market is finally giving the company's $1 billion in annual revenue a reasonable value. A retroactively instated batch of blending credits from 2012 certainly helped to boost first-quarter income to a record $46.4 million, or a profit margin of 14%. Of course, uncertainty in mandates and production volume obligations seems to punish REG at the end of each year. The nation has plenty of overcapacity to switch on -- or export -- and biodiesel is far from facing the blending constraints of ethanol. So I think the company's future is pretty safe for the time being.
- [By Maxx Chatsko]
RINs are created with each lot of biofuels produced and act as a way for the industry to track production. They are normally sold with the corresponding amount of biofuels, but can be sold on secondary markets without a physical volume to back it up. Speculation by third parties and fear of running into the 10% ethanol blend wall in 2013 and 2014 caused prices to spike. The volatility may continue for the medium term, but investors may be able to find solace in the country's leading biodiesel producer Renewable Energy Group (NASDAQ: REGI ) . Fool contributor Maxx Chatsko explains why in the following video.
No comments:
Post a Comment